True Health Medical-B / 真健康医疗-B

Summary

About

About True Health Medical-B / 真健康医疗-B

TH-S1 combines CT-image analysis, puncture-path planning, optical navigation, robotic positioning and respiratory tracking. The physician identifies the target and reviews the proposed trajectory, while the arm aligns the needle guide with the planned entry point and angle. Respiratory-phase monitoring helps coordinate insertion around motion of the chest or abdominal organs.

The wider product family includes TH-S, TH-S Pro and TH-SA variants for puncture and ablation workflows. True Health supplies the robot, planning software, clinical training and technical support to hospitals, while the clinician retains control of treatment decisions and needle execution. All four flagship variants hold Chinese Class III registrations, and the company began trading in Hong Kong on June 30, 2026.

PRICE
Range 1Y
Return
High
Low
Updated

Team

  • Cheong Hou Iam - Chairperson, Executive Director and General Manager - Leads True Health Medical as it advances percutaneous puncture and ablation surgical robots through Hong Kong IPO subscription and planned listing.

Timeline

Events

Context

Comparable profiles

Shared workflows

Context tags

  • Robot-assisted procedure workflow - Workflow - The company develops and commercializes surgical robots.
  • Surgical robot OEM - Stack Layer - The company builds its TH-S puncture surgical robot family.
  • Surgical navigation and planning - Capability - Its puncture robots support lesion identification, path planning and procedure guidance.
  • Surgical medical intervention - Workflow - The robots support percutaneous puncture and ablation intervention workflows.
  • Hospitals and surgical centres - Customer Environment - The product family is built for surgical and interventional hospital workflows.